FDA Inspection 964809 — Hexal AG
The FDA completed an inspection of Hexal AG on Feb 19, 2016 in Holzkirchen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 19, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Holzkirchen (Germany)
Additional details
Sponsor, Contract Research Organization